{"filings":[{"id":110231,"accession_number":"0001185185-26-000736","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2026-03-03T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"VSee Health shareholders approve private placement issuance of up to 19.7M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved issuance of up to 19,672,130 common shares to warrant holders under Nasdaq Rule 5635(d).","Votes: 14,109,726 FOR, 7,698,963 AGAINST, 16,188 ABSTAIN.","Adjournment proposal withdrawn after private placement proposal passed; received 18,629,017 FOR.","Quorum achieved with 21,824,877 shares represented (50.46% of outstanding).","Record date Feb 2, 2026; 43,244,355 common shares and 1,559 preferred shares outstanding."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.15,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110230,"accession_number":"0001185185-26-000625","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2026-02-19T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"VSee Health to acquire 10% of GoMyRx for $2M in stock; enters managed services agreement","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["VSEE to purchase $2.0M of GMRx common stock via issuance of own stock, representing 10% ownership.","Managed services agreement: VSEE provides platform admin, support, and vendor coordination at cost plus 10%.","MSA term through Dec 26, 2027, with 6-month extension option; GMRx may terminate on 20 days' notice.","Stock purchase consideration is VSEE shares; all shares fully vested on effective date (Jan 16, 2026).","GMRx is a digital prescription fulfillment platform and affiliate of the GoMyDocs healthcare ecosystem."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":110229,"accession_number":"0001185185-26-000009","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2026-01-02T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"VSee Health annual meeting elects directors, ratifies auditor, approves equity plan","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["35.74% quorum; 11,539,193 shares present at Dec 30, 2025 annual meeting.","Dr. Milton Chen and Dr. Imoigele Aisiku elected Class I directors with ~10.4M and ~10.3M 'for' votes.","Ratified WWC, P.C. as auditor for FY2025: 11,216,618 for, 320,838 against.","Approved VSee Health 2025 Equity Incentive Plan: 9,536,835 for, 1,259,406 against.","Adjournment proposal withdrawn as all other proposals passed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126802,"accession_number":"0001185185-25-002102","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-12-18T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"VSee Health amends bylaws to reduce stockholder meeting quorum to 33.33%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board approved amendment on Dec 17, 2025 reducing quorum to one-third of voting power.","Quorum change applied retroactively to the 2025 Annual Meeting set for Dec 30, 2025.","Annual meeting to be held via live webcast at 2:30 p.m. eastern time.","Amendment to Bylaws filed as Exhibit 3.1 to this 8-K."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126801,"accession_number":"0001185185-25-002039","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-12-12T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"VSee Health postpones 2025 Annual Meeting to Dec 30; cites insufficient quorum","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Meeting postponed from Dec 15 to Dec 30, 2025 at 2:30 p.m. ET due to anticipated lack of quorum.","Record date remains Nov 20, 2025; all proposals and voting instructions unchanged.","Company continues soliciting proxies; stockholders must vote by Dec 29, 2025 at 11:59 p.m. ET.","No changes were made to the proposals set forth in the Nov 24 proxy statement."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126800,"accession_number":"0001185185-25-002025","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-12-11T23:59:59+00:00","items":["5.03","9.01"],"status":"ready","headline":"VSee Health designates Series B Convertible Preferred Stock with $0.65 conversion price","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Filed Certificate of Designation for 2,000 shares of Series B Preferred Stock, $1,000 stated value.","Dividends paid on as-converted-to-common basis only when common dividends paid.","Shares convertible into common at $0.65 per share, subject to 9.99% beneficial ownership cap.","Liquidation preference senior to common, pari passu with Series A Preferred Stock.","Conversion exercisable after investor gross proceeds from sale of all investor shares are less than $2.3M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126789,"accession_number":"0001185185-25-002019","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K/A","filed_at":"2025-12-11T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"VSee Health reports pro forma equity of $9.5M, regains Nasdaq continued listing compliance","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Pro forma equity of $9.5M as of Dec 1, 2025, up from ($18,488) deficit at Dec 31, 2024.","Transactions: $8.1M in convertible notes converted to equity, warrant exchange ($1.5M), and $6M PIPE.","Nasdaq Hearings Panel granted exception after company demonstrated compliance with Equity Rule 5550(b)(1).","Company closed debt conversions, warrant exercises, and private placement between Oct and Nov 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126799,"accession_number":"0001185185-25-001884","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-11-28T23:59:59+00:00","items":["8.01","9.01"],"status":"ready","headline":"VSEE Health regains Nasdaq equity compliance; pro forma equity $13.2M vs $2.5M minimum","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders' deficit of $18,488 at Dec 31, 2024 was below Nasdaq's $2.5M minimum for continued listing.","After warrant exercises, convertible note/preferred conversions, and payable exchanges, pro forma equity is $13.2M.","Nasdaq Panel granted exception; company must demonstrate compliance by Dec 1, 2025, which it believes it has.","Pro forma balance sheet filed as Exhibit 99.1 showing $13,216,722 in stockholders' equity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126798,"accession_number":"0001185185-25-001870","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-11-26T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"VSee Health raises ~$6M in private placement of common shares and warrants","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of ~$6M from sale of 9.8M shares (or pre-funded warrants) and 19.7M common warrants at $0.61/unit.","Common warrants exercisable at $0.61/share, expire 5 years from exercise date, subject to stockholder approval.","Net proceeds for working capital and general corporate purposes; closing expected ~Dec 1, 2025.","Placement agent A.G.P./Alliance Global Partners receives 7% cash fee; company restricted from equity issuances for 90 days.","Officers and directors enter 90-day lock-up agreements from closing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126797,"accession_number":"0001185185-25-001777","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["1.01","2.03","3.02","9.01"],"status":"ready","headline":"VSee Health issues $217K convertible note at 18% interest, $0.48 conversion price, plus 50K shares","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Initial principal $217,391; net proceeds $201,000 (8% OID) to VSee Health from M2B Funding Corp.","Interest 18% p.a.; first 8 months guaranteed; maturity Oct 29, 2026.","Conversion at $0.48/share after Jan 29, 2026; prepayment allowed with 10% fee.","Note secured by all company assets; investor has right to buy additional note for 12 months.","50,000 shares of common stock issued to investor for $1,000 as Additional Equity Stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126796,"accession_number":"0001185185-25-001763","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-11-17T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"VSee Health exchanges $612K note for 941K shares and enters $25M ELOC","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exchanged $611,878.22 promissory note for 941,352 common shares; note cancelled.","Secured $25M equity line of credit (ELOC) via directed stock purchase agreement; 36-month term.","ELOC pricing: 96% of 10-day low VWAP (94% if price below $1.00); expanded purchase up to $5M.","Sales capped at 19.9% of outstanding shares; proceeds for working capital and corporate purposes.","Both transactions with accredited institutional investors; unregistered under Sections 3(a)(9) and 4(a)(2)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126795,"accession_number":"0001185185-25-001563","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-10-29T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"VSee Health warrants exchange with Alta: 2.25M warrants for 2.175M shares","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Exchanged 2,250,000 IPO warrants with Alta Partners for 2,175,000 common shares; 130,000 warrants exercised for cash.","Shares issued under Section 3(a)(9) exemption; no restrictive legends.","Company agreed to 10-day standstill: no new equity issuances, reverse splits, or registration filings.","Alta Partners represents it is not an affiliate or >10% beneficial owner of VSee."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126794,"accession_number":"0001185185-25-001551","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-10-28T23:59:59+00:00","items":["5.08","8.01"],"status":"ready","headline":"VSee Health sets 2025 annual meeting for December 15; proposal deadline November 7","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Annual meeting scheduled for December 15, 2025; record date November 20, 2025.","Stockholder proposals must be received by November 7, 2025, for inclusion in proxy materials.","Universal proxy rule compliance requires notice by November 7, 2025, for director nominees."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126793,"accession_number":"0001185185-25-001518","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-10-22T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"VSee Health lowers convertible note conversion price to $0.75 per share","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amendment to $2,222,222 senior secured convertible promissory note dated Sept 30, 2024.","New conversion price set at $0.75 per share; prior price unspecified but higher.","Note held by Ascent Partners Fund LLC; all other terms remain unchanged.","Company reaffirms obligations and liens under the transaction documents."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126792,"accession_number":"0001185185-25-001496","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-10-20T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"VSee Health issues $133k secured note, terminates equity line with Dominion","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $133,333.33 secured note for $120,000 (10% OID), 5% interest, matures May 20, 2026, non-convertible.","Note fully secured by all assets of VSee and its subsidiaries under amended security agreements.","Terminated Equity Purchase Agreement with Dominion effective October 18, 2025, ending the equity line.","Covenants prohibit variable-rate transactions and require most-favored-nation terms to investor.","Proceeds used for general corporate purposes; existing security agreements amended to include this note."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126791,"accession_number":"0001185185-25-001434","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-10-14T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"VSee Health dismisses auditor Withum, appoints WWC as new independent auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed WithumSmith+Brown as auditor effective Sept 15, 2025; no disagreements or reportable events except material weaknesses from 2024 10-K.","Appointed WWC, P.C. effective Sept 18, 2025, after Audit Committee competitive review.","WWC to audit FY 2025 and review interim periods for Q1-Q3 2025.","Prior auditor's report included going concern explanatory paragraph about the company's ability to continue.","No consultations with WWC on accounting principles or disagreements prior to appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":126790,"accession_number":"0001185185-25-001417","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-10-10T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"VSee Health issues $133K secured note, amends security agreements with Dominion and Ascent","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued secured note of $133,333.33 principal at 5% interest, purchase price $120,000, maturing May 8, 2026.","Note is not convertible; events of default trigger interest up to 24% per annum upon acceleration.","Amendment extends existing security agreements and guaranties to cover note, fully secured by company and subsidiary assets.","Dominion Capital and Ascent Partners consented, waiving defaults arising from this transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143578,"accession_number":"0001185185-25-001289","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-09-29T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"VSee Health receives Nasdaq bid price deficiency letter; faces multiple listing non-compliance issues","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq staff notified VSee on Sep 24, 2025 that common stock bid price closed below $1.00 for 30 consecutive business days.","Company has 180 calendar days, until March 23, 2026, to regain compliance by closing at $1.00+ for 10 consecutive days.","Also not in compliance with timely filing of Q1 and Q2 2025 10-Qs and minimum stockholders' equity of $2.5M.","Company intends to monitor bid price and consider options, including a potential reverse stock split.","If not cured, VSee's common stock and public warrants may be delisted from Nasdaq."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143577,"accession_number":"0001185185-25-001135","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-09-05T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"VSee Health receives additional Nasdaq delisting notice for equity deficiency; hearing Sept 9","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Stockholders' equity of -$18,488 as of Dec 31, 2024, below the $2.5M minimum for continued listing.","Company already faces delisting for late filings; hearing before Nasdaq Panel scheduled Sept 9, 2025.","If delisted, expects common stock (VSEE) and warrants (VSEEW) to trade on OTC Markets upon suspension.","No assurance Panel will grant stay, reverse determination, or that company can regain compliance.","Trading has not yet been suspended as of filing date but may be suspended at any time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143576,"accession_number":"0001104659-25-084843","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-08-28T23:59:59+00:00","items":["4.02"],"status":"ready","headline":"VSee Health restates 2023-2024 financials due to 12 errors; material weaknesses in controls","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Prior annual and interim financial statements from 2023 and 2024 periods are no longer reliable and will be restated.","Errors include failure to accrue sales/use taxes, incorrect revenue cutoff, and misrecognized SPAC/iDoc accrued expenses.","Management identified material weaknesses in internal control over financial reporting and ineffective disclosure controls.","Restated financial statements will be filed in the 2024 Form 10-K; aggregate effects not yet quantified."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143575,"accession_number":"0001104659-25-081950","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-08-22T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"VSee Health receives Nasdaq deficiency for late Q2 10-Q; delisting hearing Sept 9","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received additional Nasdaq deficiency notice on Aug 20, 2025 for failure to timely file Q2 2025 Form 10-Q.","Trading suspension stayed until Aug 28, 2025; Nasdaq Panel hearing scheduled Sept 9, 2025.","Company expects common stock (VSEE) and warrants (VSEEW) to trade on OTC Markets after suspension if no extension granted.","Prior deficiency (Aug 5, 2025) for late 2024 10-K and Q1 2025 10-Q; appeal already filed.","Company intends to file the late 10-Q as soon as practicable and address all filings at the Panel hearing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":143574,"accession_number":"0001104659-25-075813","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-08-11T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"VSee Health receives Nasdaq delisting determination; trading suspended Aug 14","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq denied VSee's request to continue listing due to late Form 10-K and 10-Q filings.","Trading in VSEE common and VSEEW warrants suspended at open on August 14, 2025.","Company will request reconsideration; shares expected to trade on OTC Markets from Aug 14.","No assurance that appeal or reconsideration will succeed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161775,"accession_number":"0001558370-25-008313","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-05-30T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"VSee Health receives Nasdaq delisting notice for late 10-Q filing","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Nasdaq staff notified VSEE on May 23, 2025 of non-compliance with Listing Rule 5250(c)(1) due to failure to timely file Form 10-Q for period ended March 31, 2025.","Company has 60 calendar days to submit a compliance plan; if accepted, Nasdaq may grant up to 180 days from the original due date (until October 13, 2025) to file the Form 10-Q.","No immediate effect on listing of common stock (VSEE) or warrants (VSEEW); trading continues normally pending compliance process.","Management intends to submit a compliance plan and file the Form 10-Q within the 60-day period, but no assurance is given that Nasdaq will grant an exception or that compliance will be achieved."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":161774,"accession_number":"0001104659-25-046217","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["3.01"],"status":"ready","headline":"VSee Health receives Nasdaq delisting notice for failure to file 2024 10-K","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on April 25, 2025 for non-compliance with Listing Rule 5250(c)(1) due to late Form 10-K.","Has 60 calendar days to submit a compliance plan; Nasdaq may grant up to 180-day extension to October 13, 2025.","Company cites additional time needed to compile audited financials after June 2024 de-SPAC merger.","Trading of VSEE common stock and VSEEW warrants continues; no immediate delisting effect.","No assurance that plan will be submitted or that compliance will be achieved within allowed period."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179865,"accession_number":"0001104659-25-026681","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-03-21T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"VSee Health issues $555.6K secured note and $108.7K note; amends equity purchase agreement","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Issued senior secured note for $555,555.56 at 5% interest, maturing Nov 1, 2025, plus 100,000 commitment shares.","Issued second secured note for $108,695.65 at 18% interest, convertible, maturing Dec 20, 2025, plus 25,000 shares.","Amended Equity Purchase Agreement floor price to $1.25 per share from previous floor.","Notes are secured by collateral; subsidiaries guarantee obligations under the notes.","Both notes issued to accredited institutional investors; funds used for general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179864,"accession_number":"0001104659-25-007642","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-01-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health announces $870K contract renewal with national mental health services provider","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Contract renewal with nationwide mental/behavioral healthcare provider valued at ~$870K.","Renewal underscores VSee's client retention and platform value for high-quality mental healthcare.","Platform includes PHQ-9/GAD-7 assessments, custom intake forms, and no-download patient experience.","Digital mental health market expected to grow from $23.63B in 2024 to $27.56B in 2025 (16.6% CAGR)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179863,"accession_number":"0001104659-25-006352","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-01-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health announces ~$935K in medtech contracts for remote device support","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Contracts with multiple medical device companies total ~$935,000.","VSee platform provides remote support, remote operation, and lossless screen sharing for devices.","Global medtech market estimated at $800B by 2030 per Fortune Business Insights.","Platform already integrated with devices and submitted for combined FDA approval."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179862,"accession_number":"0001104659-25-004152","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2025-01-16T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health nets $6M government contract and $160K Florida health system deal","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Awarded a multi-year government contract with $6M allocated for the first year to deploy customizable telehealth platform.","Secured a $160,000 contract with a prominent Florida health system for home health and TeleNursing services.","Both contracts leverage VSee's modular 'Lego-like' digital health building blocks with EHR integration.","Contracts position VSee for growth in hospital and government telehealth markets with renewal potential."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196653,"accession_number":"0001104659-24-131356","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-12-23T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health awarded Premier GPO agreement and $1.5M ARR teleradiology contract with large hospital system","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["National group purchasing agreement with Premier, Inc. effective September 1, 2024; allows Premier members special pricing on teleradiology services.","Secured teleradiology contract with one of the largest U.S. post-acute care hospital systems; launch in Q1 2025.","Initial rollout covers three hospitals, representing potential $1.5 million in annual recurring revenue; contract auto-renews annually.","VSee's teleradiology solutions enable remote interpretation of X-rays, MRIs, and CT scans, improving diagnostic efficiency and flexibility."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196652,"accession_number":"0001104659-24-129800","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-12-18T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health partners with Tele911 to launch virtual ED, targeting 10M+ lives by end-2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Partnership combines VSee's telehealth platform with Tele911's ER diversion solution to address ER overcrowding and EMS staffing shortages.","Tele911 model has served 7M+ lives across 17 locations in 4 states, saving $28.8M from fewer than 10,000 consultations.","Average care delivery time is 40 seconds; VSee's HIPAA-compliant tech enables Tele911 to onboard 300+ new fire/EMS agencies.","Target to expand Tele911's reach to over 10 million lives by the end of 2025.","Co-CEO Dr. Milton Chen and Tele911 CEO Dr. Ramon Lizardo quoted on game-changing impact for EMS industry."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196651,"accession_number":"0001104659-24-127663","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health partners with AbundaBox to launch AbundaLife health record platform at $34/year","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Strategic partnership with AbundaBox to launch AbundaLife, a health record management platform.","Platform consolidates personal health data into one secure profile; priced at $34 per patient per year.","Initial rollout includes eight healthcare facilities, demonstrating early market adoption.","Built on VSee Health's AI telehealth technology; integrates telehealth support and billing services.","Company cites potential for revenue acceleration and improved care coordination."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196650,"accession_number":"0001104659-24-122614","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-11-25T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health partners with TeleDentists for virtual oral health compliance on PointClickCare Marketplace","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Partnership integrates virtual dentistry into PointClickCare for long-term care compliance with CMS oral health regulations.","Provides 24/7/365 on-demand licensed dentists to skilled nursing and long-term care facilities.","Integration reduces documentation burden by syncing telehealth interactions with PointClickCare platform.","Dr. Milton Chen (Co-CEO) and Dr. Maria Kunstadter (CEO of TeleDentists) commented on improving senior oral health outcomes.","This is the first and only PointClickCare Marketplace integrated solution offering virtual oral health compliance services."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196649,"accession_number":"0001104659-24-121065","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-11-20T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health expands Africa telehealth pilots under Clinton Global Initiative commitment","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Expanding Project VITAL Africa telehealth pilots in Cameroon, originally committed at Clinton Global Initiative 2023.","Two pilots launched in Yaounde in early 2024 using VSee platform; expanding to remote North/Northwest regions.","Partnering with Sand Technologies, ALX Africa, African Leadership University to bring in local coders and programmers.","Regions with over 30M people needing humanitarian and mental health support, high maternal mortality rates.","Other commitment partners include Boston Medical Center, Stanford Medicine, Yale Institute for Global Health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196648,"accession_number":"0001104659-24-120176","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-11-18T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"VSee Health Q3 revenue up 131% to $3.4M; net loss $51.8M on $55M goodwill impairment","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2024 revenue $3.4M (up 131% YoY); 9-month revenue $6.6M (+51%).","Net loss $51.8M in Q3 driven by $55M goodwill impairment; pro forma net loss $0.4M ($(0.02)/share).","Cash $2.3M at Sept 30; no guidance provided.","Pro forma 9-month net loss $(0.16)/share vs $(0.24)/share a year ago.","Expanded partnerships with Seven Corners, SkywardRx, Ava Robotics; launched Aimee and GLP-1 telehealth program."],"consensus_eps_estimate":null,"consensus_eps_actual":-6.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":6686998.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196647,"accession_number":"0001104659-24-112670","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-10-30T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health partners with BabyLiveAdvice for virtual maternal care platform","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["VSee Health partners with BabyLiveAdvice to power its virtual maternal care platform for hospitals and FQHCs.","Partnership aims to fill staffing gaps and improve access in U.S. maternity deserts covering 2.3M women.","No financial terms or revenue projections disclosed in the announcement.","Platform addresses non-clinical care (education, monitoring, lactation, mental health) from pregnancy to postpartum.","VSee CEO Dr. Milton Chen says technology crucial for health equity."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196646,"accession_number":"0001104659-24-110600","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-10-22T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health launches GLP-1 telemedicine program for obesity at $4.99/month","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["GLP-1 program combines telehealth access, prescription drug support, and behavioral intervention for weight management.","Subscription cost is $4.99 per month; includes virtual appointments and personalized care plans.","Company partners with National Black Baptist Association to raise awareness of obesity and cardiovascular disease.","Initiative expands VSee Health's existing virtual urgent care, primary care, and wellness services."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196645,"accession_number":"0001104659-24-109576","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-10-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health, Kwajalein Atoll launch sea ambulance telehealth for Marshallese veterans","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Used Starlink satellite and VSee Telemedicine Kit on boat ambulance to connect remote patients with land-based doctors; demo completed July 25, 2024.","Two US Coast Guard Academy cadets, after 30 min training, performed remote physical exam on a Marshallese U.S. Army veteran.","Partnership with Kwajalein Atoll Local Government and Sustainability Laboratory; Mayor Kabua and CEO Chen praised initiative.","Targets healthcare access for ~10,000 residents of Ebeye Island and outer islands lacking trained health personnel.","Physicians in Hawaii, Washington, and Florida observed live exam via VSee 'Medical Apprentice' mode."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196644,"accession_number":"0001104659-24-108087","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-10-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health co-CEO to speak at STAR-TIDES fireside chat Oct 22 and iA-Med 2024 keynote Oct 16","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Co-CEO Milton Chen will speak on digital health transformation and cybersecurity at STAR-TIDES fireside chat on Oct 22 at 1:00 p.m. PT.","Chen will deliver a keynote at iA-Med 2024 symposium on AI in healthcare on Oct 16 in San Salvador.","Events focus on telehealth security and AI applications; no financial or operational updates provided."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196643,"accession_number":"0001104659-24-104479","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-10-01T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"VSee Health issues $2.22M senior secured convertible notes due 2026, warrants at $2.25, 100K commitment shares","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Principal $2,222,222.22 at 10% interest, due March 30, 2026; secured by substantially all assets including IP.","Investor receives 740,741 warrants (5-year, $2.25 strike) and 100,000 commitment shares of common stock.","Note convertible into common stock, subject to 4.99% beneficial ownership cap.","Directors and officers entered lock-up agreements until note is outstanding.","Registration rights agreement requires filing to register shares underlying note, warrants, and commitment shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212952,"accession_number":"0001104659-24-102074","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-09-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"VSee Health Q2 revenue up 33% to $1.7M; net loss narrows to $0.3M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $1.7M (+33% YoY); net loss $0.3M ($0.06/shr) vs $0.4M net loss in prior-year quarter.","Completed de-SPAC merger on June 24, 2024; now trades on Nasdaq under VSEE.","Partnered with Ava Robotics for telehealth robot; launched Aimee, a low-cost virtual care service for uninsured patients.","Contract with Seven Corners Correctional Health for 24 federal prisons; secured Premier virtual care purchasing agreement.","Cash and equivalents $1.1M; pro forma net loss $1.8M ($0.12/shr) for Q2 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212951,"accession_number":"0001104659-24-098939","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-09-11T23:59:59+00:00","items":["3.01","7.01","9.01"],"status":"ready","headline":"VSee Health receives Nasdaq delinquency notice for late Q2 2024 10-Q filing; has 60 days to submit compliance plan","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Received Nasdaq notice on Sept 6, 2024 due to missing Q2 2024 Form 10-Q deadline; must respond by Nov 5, 2024.","If compliance plan is accepted, Nasdaq may grant extension until Feb 18, 2025 to file the overdue 10-Q.","Notice has no immediate effect on trading; VSEE common stock and VSEEW warrants continue listed on Nasdaq.","Delay caused by valuations related to de-SPAC acquisition of iDoc Virtual Telehealth Solutions completed in June 2024.","Company intends to file Form 10-Q as soon as practicable and regain compliance with Nasdaq listing rules."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212950,"accession_number":"0001104659-24-087305","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-08-08T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health launches Aimee telehealth service in Wichita with Stand Together at $4.99/month","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Aimee offers virtual urgent care ($9.99), primary care ($29.99), and medical weight loss with exercise programs.","Service launched on July 13, 2024, targeting underserved communities via local community centers.","Monthly membership is $4.99; available to patients with or without health insurance.","Partnership with Stand Together aims to expand access to affordable, personalized healthcare.","VSee Health co-CEO Milton Chen highlighted the modular software integration with community centers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212949,"accession_number":"0001104659-24-085389","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-08-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health partners with Ava Robotics for ICU telepresence robot","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Partnership to develop VSee-powered Ava Robot for inpatient ICU telepresence.","Robot will be autonomous in ICU, enabling remote physicians to interact and make treatment decisions.","Goal to expand telehealth access to regional hospitals and smaller ICUs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212948,"accession_number":"0001104659-24-083587","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-07-29T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health partners with SkywardRx to provide telehealth and billing services","summary_kind":"llm","event_type":"other_material","confidence":"medium","bullets":["Partnership targets SkywardRx's nonprofit, hospital, and Fortune 20 corporate clients.","Services cover behavioral health, nutritional wellness, and substance abuse.","VSee's turnkey technology and billing combined with SkywardRx's consulting.","Potential to serve approximately five million patients via SkywardRx's client base."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212947,"accession_number":"0001104659-24-081912","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-07-23T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"VSee Health expands board to seven, appoints Fairfax and Wickersham as Class III directors","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board increased from 5 to 7 members; Fairfax and Wickersham appointed as Class III directors effective July 17, 2024.","Fairfax appointed to Audit Committee and as chair of Nominating Committee; Wickersham appointed chair of Compensation Committee.","Fairfax is EVP & General Counsel of Metro (Harris County transit) and previously SVP at American Capital; both directors independent per Nasdaq.","Wickersham held a $224k secured convertible note from subsidiary iDoc, satisfied with 114k shares; no other related-party transactions.","Director compensation has not yet been determined by the Board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212946,"accession_number":"0001104659-24-079872","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-07-15T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"VSee Health begins outpatient telehealth services for Federal Bureau of Prisons","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Contract with Seven Corners Correctional Health, operator of 24 federal prisons.","Rollout starts at FCI Williamsburg (SC), FCI Loretto (PA), FDC SeaTac (WA), FCI Bastrop (TX).","Specialties include cardiology, nephrology, gastroenterology, psychiatry, orthopedics, and more."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":212945,"accession_number":"0001104659-24-078566","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-07-09T23:59:59+00:00","items":["1.01","5.05","9.01"],"status":"ready","headline":"VSee Health extends $3M Quantum Note maturity to 2026, issues $500k convertible note","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Amended $3M Quantum Note: maturity extended to June 30, 2026; 12% annual interest (18% on default), 18 months interest guaranteed.","Issued $500k Equity Purchase Commitment Note payable only in common stock at $10/share, due September 22, 2024.","Amendment executed with Quantum Assets SPV LLC; note originally issued June 25, 2024 under existing purchase agreement.","Adopted updated Code of Ethics to reflect name change from Digital Health Acquisition Corp. to VSee Health."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232028,"accession_number":"0001104659-24-076308","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-06-28T23:59:59+00:00","items":["1.01","2.01","5.06","9.01","3.02","4.01","3.03","5.03","5.01","5.02","7.01"],"status":"ready","headline":"VSee Health completes business combination with VSee Lab and iDoc; name change effective","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["DHAC merged with VSee Lab and iDoc; renamed VSee Health, Inc.; shares reclassified.","Total shares outstanding: ~14.69M; public shares only 114,966.","Issued $3.0M 7% OID convertible note (Quantum Note) to institutional investor.","$2.52M Exchange Note issued to bridge investor, secured by IP assets.","Issued 4,370 Series A Preferred to A.G.P. and 1,788 Series A to lenders per loan conversion."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232027,"accession_number":"0001104659-24-070843","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-06-12T23:59:59+00:00","items":["5.07","8.01"],"status":"ready","headline":"Stockholders approve business combination with VSee Health, no redemptions","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Business Combination with VSee Health approved by 3,233,699 votes (all FOR), none against or abstain.","Name change to 'VSee Health, Inc.' approved; authorized shares increased to 100M common, 10M preferred.","Five directors elected: Milton Chen, Imoigele Aisiku, Kevin Lowdermilk, Colin O'Sullivan, Scott Metzger.","No shares of common stock were tendered for redemption in connection with the Special Meeting.","All 12 proposals passed, including equity incentive plan and multiple financing authorizations."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":232026,"accession_number":"0001104659-24-056414","cik":1864531,"company_name":"VSEE HEALTH, INC.","ticker":"VSEE","form_type":"8-K","filed_at":"2024-05-02T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Digital Health Acquisition extends business combination deadline to Aug 8, 2024","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Third of four permitted three-month extensions exercised; prior deadline was May 8, 2024.","Extension provides additional time to complete a qualifying business combination before liquidation.","Company had not yet consummated a de-SPAC transaction as of filing date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":7390000.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":"2024-05-02T23:59:59+00:00|232026"}